[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336525-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336525-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","combined-microfluidic-enrichment-and-staining-workflow-for-single-cell-analysis-of-circulating-tumor-cells-in-metastatic-prostate-cancer-patients","Combined microfluidic enrichment and staining workflow for single-cell analysis of circulating tumor cells in metastatic prostate cancer patients","","Circulating tumor cells (CTCs) are promising biomarkers for dynamic monitoring of cancer progression and tumor heterogeneity, yet their low abundance in blood has limited clinical adoption. This study presents a streamlined workflow using cytokeratin staining with the FDA-cleared Parsortix size-based microfluidic enrichment device. To reduce handling loss, cells are stained inside the separation cassette, harvested, then used for single-cell isolation and whole-genome copy-number analysis. The workflow is validated on prostate cancer cell lines spiked into donor blood and tested in metastatic prostate cancer patients, with single CTC isolation supporting genomic characterization linked to treatment response.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/combined-microfluidic-enrichment-and-staining-workflow-for-single-cell-analysis-of-circulating-tumor-cells-in-metastatic-prostate-cancer-patients/336525/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/combined-microfluidic-enrichment-and-staining-workflow-for-single-cell-analysis-of-circulating-tumor-cells-in-metastatic-prostate-cancer-patients/336525.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are circulating tumor cells (CTCs) important in cancer monitoring?","Question",{"text":63,"@type":64},"CTCs are precursors of cancer in the blood and can support dynamic monitoring of disease progression and tumor heterogeneity through blood sampling.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What workflow does this study propose for detecting CTCs?",{"text":68,"@type":64},"The study describes cytokeratin staining combined with the FDA-cleared Parsortix device for size-based microfluidic enrichment. Staining is performed inside the separation cassette to minimize sample handling loss, followed by single-cell isolation and whole-genome copy-number analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"How was the workflow validated and what did it show clinically?",{"text":72,"@type":64},"It was validated using prostate cancer cell lines spiked into healthy donor blood, achieving mean recoveries of 42% (16–69%). In a cohort of 12 metastatic prostate cancer patients, CTCs were found in 67% of patients.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336525,1790142512,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nCombined microfluidic enrichment and staining workflow for single‑cell analysis of circulating tumor cells in metastatic prostate cancer patients  \nCaroline Løppke1, Amalie M. Jørgensen1, NicolaiT. Sand1, Rasmus B. Klitgaard2, Gedske Daugaard3 & Mette Ø. Agerbæk1*  \nCirculating tumor cells (CTCs) are precursors of cancer in the blood and provide an attractive source for dynamic monitoring of disease progression and tumor heterogeneity. However, the scarcity of CTCs in the bloodstream has limited their use in clinical practice. In this study, we present a workflow for easy detection of CTCs by cytokeratin staining using the FDA‑cleared Parsortix device for size‑ based microfluidic enrichment. To minimize sample handling, the isolated cells are stained inside the separation cassette and harvested for subsequent single cell isolation and whole genome copy‑ number analysis. We validated the workflow on a panel of four prostate cancer cell lines spiked into healthy donor blood collected in CellRescue or EDTA tubes, resulting in mean recoveries of 42%(16–69%). Furthermore, we evaluated the clinical utility in a cohort of 12 metastatic prostate cancer patients and found CTCs in 67% of patients ranging from 0 to 1172 CTCs in 10 mL blood. Additionally, we isolated single patient‑derived CTCs and identified genomic aberrations associated with treatment response and clinical outcome. Thus, this workflow provides a readily scalable strategy for analysis of single CTCs, applicable for use in monitoring studies to identify genomic variations important for guiding clinical therapy decision.  \nAbbreviations  \nAR Androgen receptor  \nBSA Bovine serum albumin  \nCK Cytokeratin  \nCNA Copy-number alteration  \nCRPC Castration-resistant prostate cancer CTC Circulating tumor cell  \nDAPI 4′,6-diamidino-2-phenylindole EDTA Ethylenediamine tetraacetic acid EGFR Epidermal growth factor receptor EpCAM Epithelial cell adhesion molecule FDA Food and Drug Administration  \nHER2 Human epidermal growth factor receptor 2 HSPC Hormone-sensitive prostate cancer  \nc-MET Hepatocyte growth factor receptor  \nMNC Mononuclear cells  \nNSCLC Non-small cell lung cancer  \nPARP Poly(adenosine diphosphate-ribose) polymerase  \n1Centre for Translational Medicine and Parasitology at Department for Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 2Flow Cytometry and Single Cell Core Facility, Department for Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. 3Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.*[email: mettea@sund.ku.dk](email: mettea@sund.ku.dk)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nPC Prostate cancer  \nPD-L1 Programmed cell death ligand  \nWBC White blood cell  \nWGA Whole genome amplification  \nDuring tumorigenesis, malignant cells disseminate from the primary tumor into the circulation from where they reach distant organs to seed metastasis1. Circulating tumor cells (CTCs) have gained significant interest asa potential clinical biomarker as they are easily accessible via blood sampling and facilitate dynamic monitoring of disease progression and emergence of therapy resistant clones2,3. The clinical utility of CTCs has been established in metastatic breast, prostate, and colorectal cancer where the CTC level is a prognostic indicator of overall survival4–6. Furthermore, CTCs embody the tumor heterogeneity not afforded by the spatially biased tissue biopsies that are currently used as the clinical source for molecular profiling to guide therapy selection7–9. Yet, capture of CTCs is inherently challenging due to the scarcity of cancer cells in blood, which has limited its use in the clinical practice10.  \nRecently, the Food and Drug Administration (FDA) cleared the Parsortix system ","cbCaij4thOf1cQw2","https://ap.wps.com/l/cbCaij4thOf1cQw2","pdf",1540205,11,"English","# Introduction\n## Clinical relevance of circulating tumor cells\n## Challenges in CTC capture and detection\n# Parsortix microfluidic separation background\n# CTC staining strategies after Parsortix isolation\n## Harvest-then-stain approaches\n## In-cassette staining approaches","[{\"question\":\"Why are circulating tumor cells (CTCs) important in cancer monitoring?\",\"answer\":\"CTCs are precursors of cancer in the blood and can support dynamic monitoring of disease progression and tumor heterogeneity through blood sampling.\"},{\"question\":\"What workflow does this study propose for detecting CTCs?\",\"answer\":\"The study describes cytokeratin staining combined with the FDA-cleared Parsortix device for size-based microfluidic enrichment. Staining is performed inside the separation cassette to minimize sample handling loss, followed by single-cell isolation and whole-genome copy-number analysis.\"},{\"question\":\"How was the workflow validated and what did it show clinically?\",\"answer\":\"It was validated using prostate cancer cell lines spiked into healthy donor blood, achieving mean recoveries of 42% (16–69%). In a cohort of 12 metastatic prostate cancer patients, CTCs were found in 67% of patients.\"}]","Combined microfluidic enrichment and staining workflow for single-cell analysis of circulating tumor cells in metastatic prostate cancer patients | PDF",1790015440,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/890dbd4ad06031bd0bc1dca4acd14f9d.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df4e990ce900db9f1307a64c310e8576.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/905919866c8ae90032b72d7365ec2ab6.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/193dfee053d9f9e90e5cbf413197148a.webp",980,1287]